Macrophage migration inhibitory factor has a MHC class I-like motif and function.

Area of Science:

• Immunology
• Molecular Biology
• Cellular Biology

Background:

• Macrophage migration inhibitory factor (MIF) is present in immune-privileged sites.
• MIF is known to inhibit lymphokine-activated killer (LAK) cell cytotoxicity.
• The mechanism underlying MIF's attenuation of LAK cytotoxicity remains unclear.

Purpose of the Study:

• To investigate the structural and functional relationship between MIF and MHC class I.
• To elucidate the mechanism by which MIF inhibits LAK cell cytotoxicity.

Main Methods:

• Utilized monoclonal antibody (OX18) binding assays to compare MIF and MHC class I.
• Performed epitope mapping to identify binding sites.
• Assessed the effect of MIF on MHC class I tetramer binding to LAK cells.

Main Results:

• MIF exhibits a major histocompatibility complex (MHC) class I-like motif.
• The monoclonal antibody OX18, which targets MHC class I, binds native MIF.
• MIF inhibits the binding of MHC class I tetramers to LAK cells, indicating interaction with MHC class I receptors.

Conclusions:

• MIF possesses an MHC class I-like structure and may utilize MHC class I receptors to modulate immune responses.
• This structural mimicry could be a mechanism for endogenous and viral proteins to evade immune surveillance by controlling cytotoxicity.